NEW YORK, Dec. 03, 2015 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of ERBA Diagnostics, Inc. (“ERBA”) (NYSEMKT:ERB) between April 14, 2014 and November 20, 2015.
You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Southern District of Florida. If you purchased or otherwise acquired ERBA securities between April 14, 2014 and November 20, 2015, your rights may be affected by this action.To get more information go to:
http://zlk.9nl.com/erba-diagnostics
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that, throughout the Class Period, Defendants issued materially false and misleading statements and/or failed to disclose that: (1) ERBA’s accounting of intercompany transactions among its subsidiaries, including its consolidated financial statements, were improper and had an impact on reported assets and liabilities; (2) ERBA lacked adequate controls over financial reporting; (3) ERBA’s financial statements during the Class Period were materially false and misleading; and (4) as a result, Defendants’ statements about ERBA’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
If you suffered a loss in ERBA you have until February 1, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Brown-Forman and Pernod Ricard in Merger Talks to Create World's Largest Spirits Giant
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
SMIC Allegedly Supplies Chipmaking Tools to Iran's Military, U.S. Officials Warn
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth 



